Pro-inflammatory effector Th cells transmigrate through anti-inflammatory environments into the murine fetus
Introduction
During healthy pregnancy, the maternal organism develops tolerance and anti-inflammatory mechanisms. Additionally, the placenta functions as a physical and immunosuppressive barrier between mother and fetus, providing an immunoprivileged site for fetal development within the uterus. To prevent rejection of the semi-allogeneic tissues and spontaneous abortion of the fetus, the maternal immune system is equipped with several tolerance mechanisms. These mechanisms include the production of immunosuppressive asymmetric IgG Abs (AAbs) that link with paternally inherited antigens [1], expression of tryptophan metabolism enzymes, such as Indoleamine-2,3-dioxygenase, at the maternal-fetal interface that prevent immunological rejection of fetal allografts [2], and expression of non-classical MHC molecules, such as HLA-G on trophoblasts, that function to circumvent immune responses that would target the fetus as an allogeneic graft [3]. Additionally, two models suggest that T cells are directed to avoid immune responses against the fetus. One group claims that a suppressive immune environment at the placenta occurs due to expression of Th2 and anti-inflammatory cytokines, such as IL-10, IL-4, and TGFβ, in the decidua [4]. Another proposes that an increase of regulatory T cells (Tregs) in the maternal lymph vessels [5] and at the placenta [6] functions to prevent adverse immune reactions during pregnancy. Because only some immune deficiencies are associated with adverse pregnancy outcome, it is likely that several mechanisms play together to ensure positive pregnancy outcomes.
Accumulating evidence indicates that the barrier between mother and fetus is not as tight as previously believed. Because the placenta is selectively permeable and allows for diffusion, active transport, or pinocytosis [7], a transfer of circulating maternal cells into the blood of the fetus may be common during pregnancy and could explain the appearance of foreign DNA (microchimerism) within the offspring. In recent years, it has been shown that maternal hematopoietic cells persist within fetal organs such as the liver, lung, heart, adrenal gland, kidney, blood, and placenta [8], that maternal cells are present in heart tissue of male neonates with neonatal lupus syndrome [9], and that maternal cells are able to enter the fetal circulation and migrate to newborn tissues [10]. In mice, previous studies described a bi-directional cell transmigration through the placenta no matter whether maternal mice and their offspring were syngeneic or congeneic [11], [12]. In addition, the frequency of detected cells in the placenta increased during the progression of pregnancy [12]. It has been reported that specific DNA of noninherited maternal antigen (NIMA)-carrying cells is present in lymphoid and nonlymphoid tissue of neonatal and adult mice depending on the level of maternal-fetal histocompatibility [13]. Interestingly, maternal cells presenting noninherited MHC antigens in fetus and newborns increase suppression of their NIMA-allospecific T cells leading to the development of organ transplant tolerance in adult mice [14]. Furthermore, tolerance to maternal noninherited antigens is explained with maternal microchimerism detected in fetal heart, lung, liver, lymph nodes, and blood [15], [16].
Until now, diverse subsets of pro-and anti-inflammatory CD4+ T cell types including pro-inflammatory Th1 and Th17 cells have been described. Naïve CD4+ T lymphocytes can be differentiated both in and ex vivo into Th1 or Th17 cells depending on a defined cytokine milieu. Th1 cells are known to produce IFNγ as a key cytokine in the cellular immunity process and to mediate acute graft-versus-host-disease [17]. These cells also function in the induction and progression of autoimmune diseases, such as Rheumatoid Arthritis [18]. Th17 cells producing IL-17A, IL-17F, and to a lesser extent, tumor necrosis factor (TNF), IL-6, and IL-22 [19], have been demonstrated to play a critical role in the pathogenesis of autoimmune diseases, such as Rheumatoid Arthritis [20], [21]. Additionally, these cells have been demonstrated to play a role in inflammatory bowel disease [22]. Interestingly, several studies have demonstrated that a predominance of Th1-type immunity correlates with an increase in spontaneous abortion [23] and pre-eclampsia [24], while data from another study describe an increased prevalence of Th17 cells in the peripheral blood and decidua of patients with unexplained recurrent spontaneous abortion [25]. So far, it is not known whether mature pro-inflammatory effector T cells transmigrate during pregnancy into the fetus and whether either the altered environment during pregnancy within the maternal organism or the local immunosuppressive effects at the placenta functions to prevent their transmigration.
Our study provides the first example of adoptive transfer of pro-inflammatory Th1 and Th17 cells into the anti-inflammatory environment of pregnant mice. Based on recent studies of maternal cell transmigration, we demonstrate that terminally differentiated Th1 and Th17 cells are able to pass through the placenta and to persist in the fetus. Additionally, we analyze the influence of mild, asymptomatic inflammation induced by Pertussis Toxin on the transmigration of pro-inflammatory effector Th cells.
Section snippets
Mice
The animal studies (42502-2-841 Uni MD) were approved by the Landesverwaltungsamt, Halle (Fig. 1A). Female C57/B6 (Ly5.2) mice transgenic (tg) for OVA323–339-specific TCR (OT-II), female C57/B6 (Ly5.1) mice, and pregnant C57/B6 (Ly5.1) mice were bred under specific pathogen-free conditions that complied with national and institutional regulations for the care and use of laboratory animals. All mice used in the study were between the ages of 8–12 weeks. Ly5.1 female mice were mated to Ly5.1 male
Migration of pro-inflammatory Th1 and Th17 cells occurs efficiently in the anti-inflammatory environment of pregnant mice
To observe the migration and persistence of pro-inflammatory effector Th cells during pregnancy in various anti-inflammatory compartments, we extended well accepted techniques such as adoptive transfer of radioactively labeled effector T cells to pregnancy [26] (Fig. 1A). Initially, we used the congeneic marker CD45.2+ to identify transferred Th1 and Th17 cells among the fetal splenocytes after a repeated in vivo immunization of the newborns with OVA323–339 followed by antigen specific
Discussion
The immunosuppressive and anti-inflammatory environment of the blood and placentas of healthy pregnant women has been studied extensively. Here, we provide evidence that pro-inflammatory Th1 and Th17 cells can migrate to various compartments in this environment of pregnant females. These locations include the liver, spleen, intestine, lung, lymph nodes, placenta, and even fetus (1D and 2B). Homing in non-pregnant [27] and pregnant mice seems to occur with a similar efficiency. It has been
Acknowledgment
Authors thank Kathrin Kunkel, Matthias Wolff, Corinna Runte, and Beatrix Kramer for excellent technical assistance and Gerhard Jorch for his kind support. The study was supported by the Otto-von-Guericke University (grant to JW) and DFG Br1860/6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References (40)
- et al.
Myocardial-tissue-specific phenotype of maternal microchimerism in neonatal lupus congenital heart block
Lancet
(2003) - et al.
Maternal cell microchimerism in newborn tissues
J Pediatr
(2003) - et al.
Bi-directional cell trafficking between mother and fetus in mouse placenta
Placenta
(2007) - et al.
Microchimerism is strongly correlated with tolerance to noninherited maternal antigens in mice
Blood
(2009) - et al.
Autoimmune inflammation from the Th17 perspective
Autoimmun Rev
(2007) - et al.
Maternal Th1- and Th2-type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions
Cell Immunol
(1999) - et al.
Th1/Th2 balance in preeclampsia
J Reprod Immunol
(2003) - et al.
Increased prevalence of T helper 17 [Th17] cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients
J Reprod Immunol
(2010) - et al.
Adoptive transfer of experimental allergic encephalomyelitis in mice with the aid of pertussigen from Bordetella pertussis
Cell Immunol
(1984) - et al.
Fetal-maternal microchimerism in normal parous females and parous female cancer patients
Exp Hematol
(2008)
IgG asymmetric molecules with antipaternal activity isolated from sera and placenta of pregnant human
J Reprod Immunol
Prevention of allogeneic fetal rejection by tryptophan catabolism
Science
Identification of a novel MHC class I gene, Mamu-AG, expressed in the placenta of a primate with an inactivated G locus
J Immunol
Synthesis of T helper 2-type cytokines at the maternal-fetal interface
J Immunol
Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases
Mol Hum Reprod
FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua
Biol Reprod
Vierbahn. Plazenta und Eihäute
Identification of maternal hematopoietic cells in a 2nd-trimester fetus
Fetal Diagn Ther
Fetomaternal trafficking in the mouse increases as delivery approaches and is highest in the maternal lung
Biol Reprod
Influence of maternal-fetal histocompatibility and MHC zygosity on maternal microchimerism
J Immunol
Cited by (18)
Addressing microchimerism in pregnancy by ex vivo human placenta perfusion
2022, PlacentaCitation Excerpt :Serial sectioning of resulting fetuses followed by histochemistry and PCR for lacZ-expressing cells are used to define organs containing maternal cells [85,86]. More functional approaches such as the adoptive transfer of sodium chromate [Cr51] radioactive labeled effector/memory Th1 and Th17 cells to pregnant mice have been used to demonstrate transmigration of specific T cell subtypes through the placenta into the fetus [87]. Likewise, using maternal–fetal combinations of antigen transgenic mice, maternal T cells were found to cross the placenta barrier and reach fetal organs.
Maternal IL-17A in autism
2018, Experimental NeurologyCitation Excerpt :Maternal Th17 cells release effectors like IL-17A which may impact fetal development indirectly by regulating placental function and production of intermediary soluble factors that enter fetal circulation or directly by transport into the fetus. Maternal Th17 cells have been reported also to cross to the fetus themselves (Wienecke et al., 2012). In the case of MIA during pregnancy, IL-17A may be acting directly on the fetal brain at E14.5 to alter neurodevelopment resulting in ASD-like phenotypes.
Maternal microchimerism: Lessons learned from murine models
2015, Journal of Reproductive ImmunologyCitation Excerpt :Maternal cell trafficking was increased in in utero sham-injected fetuses compared with unmanipulated offspring (Nijagal et al., 2011), an observation also made in human prenatal surgery (Saadai et al., 2012). MMc was also increased upon pertussis toxin-induced asymptomatic systemic inflammation in pregnant dams (Wienecke et al., 2012). The mechanisms regulating such dynamic changes in MMc are, however, unclear.
Comparative sensitivity analyses of quantitative polymerase chain reaction and flow cytometry in detecting cellular microchimerism in murine tissues
2014, Journal of Immunological MethodsCitation Excerpt :We here amend methodological approaches to improve the detection of microchimerism specifically in a small population of cells by cellular (flow cytometry) and molecular (qPCR) techniques. The need for such detection is increasingly required in current research endeavors (Dutta and Burlingham, 2011; Wienecke et al., 2012). Moreover, we propose detection limits allowing us to reliably identify chimeric cells within small populations in addition to the evaluation of the chimeric cells' phenotype in murine tissues.
Pregnancy-induced maternal microchimerism shapes neurodevelopment and behavior in mice
2022, Nature Communications